These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 30084428)

  • 1. Oral administration of
    Chaturvedi A; Nath G
    Indian J Med Microbiol; 2018; 36(2):293-294. PubMed ID: 30084428
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection with bacteriophage KØ1 against fatal Klebsiella pneumoniae-induced burn wound infection in mice.
    Malik R; Chhibber S
    J Microbiol Immunol Infect; 2009 Apr; 42(2):134-40. PubMed ID: 19597645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of a lytic bacteriophage φKp-lyy15 of Klebsiella pneumoniae.
    Lu Y; Shi H; Zhang Z; Han F; Li J; Sun Y
    Virol Sin; 2015 Feb; 30(1):66-8. PubMed ID: 25648354
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice.
    Chhibber S; Kaur S; Kumari S
    J Med Microbiol; 2008 Dec; 57(Pt 12):1508-1513. PubMed ID: 19018021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence to support the therapeutic potential of bacteriophage Kpn5 in burn wound infection caused by Klebsiella pneumoniae in BALB/c mice.
    Kumari S; Harjai K; Chhibber S
    J Microbiol Biotechnol; 2010 May; 20(5):935-41. PubMed ID: 20519918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Bacteriophages against Emerging Lineages ST23 and ST258 of
    Thiry D; Passet V; Danis-Wlodarczyk K; Lood C; Wagemans J; De Sordi L; van Noort V; Dufour N; Debarbieux L; Mainil JG; Brisse S; Lavigne R
    Viruses; 2019 May; 11(5):. PubMed ID: 31058805
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacteriophage-loaded nanostructured lipid carrier: improved pharmacokinetics mediates effective resolution of Klebsiella pneumoniae-induced lobar pneumonia.
    Singla S; Harjai K; Katare OP; Chhibber S
    J Infect Dis; 2015 Jul; 212(2):325-34. PubMed ID: 25605867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice.
    Cao F; Wang X; Wang L; Li Z; Che J; Wang L; Li X; Cao Z; Zhang J; Jin L; Xu Y
    Biomed Res Int; 2015; 2015():752930. PubMed ID: 25879036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposome loaded phage cocktail: Enhanced therapeutic potential in resolving Klebsiella pneumoniae mediated burn wound infections.
    Chadha P; Katare OP; Chhibber S
    Burns; 2017 Nov; 43(7):1532-1543. PubMed ID: 28502784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of a bacteriophage and its depolymerase specific for K1 capsule of Klebsiella pneumoniae: implication in typing and treatment.
    Lin TL; Hsieh PF; Huang YT; Lee WC; Tsai YT; Su PA; Pan YJ; Hsu CR; Wu MC; Wang JT
    J Infect Dis; 2014 Dec; 210(11):1734-44. PubMed ID: 25001459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and genome analysis of novel bacteriophages infecting the opportunistic human pathogens Klebsiella oxytoca and K. pneumoniae.
    Park EA; Kim YT; Cho JH; Ryu S; Lee JH
    Arch Virol; 2017 Apr; 162(4):1129-1139. PubMed ID: 28028618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capsule-Targeting Depolymerase, Derived from Klebsiella KP36 Phage, as a Tool for the Development of Anti-Virulent Strategy.
    Majkowska-Skrobek G; Łątka A; Berisio R; Maciejewska B; Squeglia F; Romano M; Lavigne R; Struve C; Drulis-Kawa Z
    Viruses; 2016 Dec; 8(12):. PubMed ID: 27916936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The efficacy of Klebsiella pneumoniae bacteriophage in the therapy of experimental Klebsiella infection].
    Bogovazova GG; Voroshilova NN; Bondarenko VM
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Apr; (4):5-8. PubMed ID: 1882608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae.
    Verma V; Harjai K; Chhibber S
    Biofouling; 2010 Aug; 26(6):729-37. PubMed ID: 20711894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [RATIONAL ASPECTS OF BACTERIOPHAGES USE].
    Vakarina AA; Kataeva LV; Karpukhina NF
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (5):76-9. PubMed ID: 26829858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encapsulation of Bacteriophage in Liposome Accentuates Its Entry in to Macrophage and Shields It from Neutralizing Antibodies.
    Singla S; Harjai K; Katare OP; Chhibber S
    PLoS One; 2016; 11(4):e0153777. PubMed ID: 27115154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical treatment of Klebsiella pneumoniae B5055 induced burn wound infection in mice using natural products.
    Kumari S; Harjai K; Chhibber S
    J Infect Dev Ctries; 2010 Jun; 4(6):367-77. PubMed ID: 20601788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of vB_Kpn_F48, a Newly Discovered Lytic Bacteriophage for Klebsiella pneumoniae of Sequence Type 101.
    Ciacci N; D'Andrea MM; Marmo P; Demattè E; Amisano F; Di Pilato V; Fraziano M; Lupetti P; Rossolini GM; Thaller MC
    Viruses; 2018 Sep; 10(9):. PubMed ID: 30205588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment.
    Verma V; Harjai K; Chhibber S
    J Antimicrob Chemother; 2009 Dec; 64(6):1212-8. PubMed ID: 19808232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bacteriophages use in the treatment of pyoseptic complications in a female patient with renal allotransplant].
    Prokopenko EI; Shcherbakova EO; Vatazin AV; Budnikova NE; Iankovoĭ AG; Pasov SA; Agafonova SG
    Urologiia; 2005; (6):43-6. PubMed ID: 16419481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.